SCHEMBL11943924

SCHEMBL11943924

CCOc1ccc(COc2c(N3CCN(S(=O)(=O)c4ccccc4)CC3)cnn(-c3ccccc3)c2=O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.54
▸ DCTPP1 Q9H773 2/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.51
▸ MAPT P10636 2/20 0.51
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ ATM Q13315 1/20 0.46
▸ POLB P06746 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ GBA1 P04062 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ PPARG P37231 1/20 0.43
▸ NCOA2 Q15596 1/20 0.43
▸ NCOA1 Q15788 1/20 0.43
▸ NCOA3 Q9Y6Q9 1/20 0.43
▸ PKM P14618 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11945049 0.89 ALDH1A1 (0.55) ALDH1A1DCTPP1MAPTKMT2AL3MBTL1
SCHEMBL11943926 0.88 POLB (0.56) ALDH1A1DCTPP1MAPTMEN1KMT2A
SCHEMBL11945047 0.88 ALDH1A1 (0.56) ALDH1A1DCTPP1MAPTKMT2APOLB
SCHEMBL11943403 0.85 ALDH1A1 (0.55) ALDH1A1DCTPP1RXFP1MAPTMEN1
SCHEMBL11944374 0.83 ALDH1A1 (0.57) ALDH1A1DCTPP1RXFP1MAPTKMT2A
SCHEMBL11944525 0.83 ALDH1A1 (0.65) ALDH1A1DCTPP1RXFP1MAPTKMT2A
SCHEMBL11945030 0.83 ALDH1A1 (0.56) ALDH1A1DCTPP1RXFP1MAPTKMT2A
SCHEMBL11945028 0.81 ALDH1A1 (0.55) ALDH1A1DCTPP1MAPTMEN1KMT2A
SCHEMBL11945032 0.81 ALDH1A1 (0.57) ALDH1A1DCTPP1RXFP1MAPTKMT2A
SCHEMBL11944415 0.81 MAPT (0.53) ALDH1A1DCTPP1RXFP1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors MAN2A1, GYS2, MANBA ALDH1A1 2437/4885DCTPP1 625/4885RXFP1 3786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback